Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06561295 · ClinicalTrials.gov registry record · NA
Optimal Timing for Spontaneous Breathing Trials
A NA study of Respiration, Artificial and Weaning, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 348
- Enrollment target
- 1
- Study location
NCT06561295: Recruiting NA study of Respiration, Artificial and Weaning, sponsored by Rush University Medical Center.
NCT06561295 is a NA study of Respiration, Artificial and Weaning that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 348 participants, below the 2,353-participant average among 6 other Respiration, Artificial trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06561295, a NA study of Respiration, Artificial and Weaning, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 348 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to explore how the timing of Spontaneous Breathing Trials (SBTs) affects recovery in adult patients who are on mechanical ventilation in the ICU. SBTs are tests used to determine if a patient is ready to breathe on their own without the help of a ventilator. The study will compare two different timing strategies for these trials: one group of patients will have the test early in the morning, while the other group will have it later in the morning. By observing the outcomes, such as how long patients need to stay on the ventilator, the study hopes to find the best time to perform these trials to help patients recover more quickly and safely.
Primary Outcome
The primary outcome of this study is the duration of mechanical ventilation, which refers to the total number of days a patient remains on a mechanical ventilator in the ICU. This measure begins from the moment a patient is initially placed on the ventilator and continues until the patient is successfully extubated (the breathing tube is removed) and can breathe independently without the need for ventilatory support.
Conditions Studied
Interventions
- OTHER Later Morning Timing of Spontaneous Breathing Trials
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2024-09-17 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT06561295 shows while recruiting
NCT06561295 is an interventional study that assigns participants to a tested intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap, below the 2,353-participant average among 6 other Respiration, Artificial trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Respiration, Artificial appearing as the primary indexed condition, and to 1 intervention - of which Later Morning Timing of Spontaneous Breathing Trials is the first listed.
NCT06561295 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06561295 about?
NCT06561295 is a clinical study titled "Optimal Timing for Spontaneous Breathing Trials". This study aims to explore how the timing of Spontaneous Breathing Trials (SBTs) affects recovery in adult patients who are on mechanical ventilation in the ICU. SBTs are tests used to determine if a patient is ready to breathe on their own without the help of a ventilator. The study will compare tw...
What is the current status of trial NCT06561295?
This trial is currently recruiting. It is a NA study. The enrollment target is 348 participants. The study started on 2024-09-17. Estimated completion is 2026-12-30.
What conditions does trial NCT06561295 study?
This clinical trial studies the following conditions: Respiration, Artificial, Weaning.
What interventions are being tested in trial NCT06561295?
The interventions under investigation include: Later Morning Timing of Spontaneous Breathing Trials (OTHER).
Who is sponsoring clinical trial NCT06561295?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06561295 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiration, Artificial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
RECRUITING · NA
-
Non-inferiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation
RECRUITING · NA
-
Superiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Ventilation Alone
COMPLETED · NA
-
ABC Trial: Awakening and Breathing Controlled
COMPLETED · NA
-
Feasibility of Ventilation Detection Via Standard Defibrillator Pads in Mechanically Ventilated Pediatric Patients
COMPLETED
-
Effects of Sternal Wall Pressure in Children
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI